WEDNESDAY, Nov. 13, 2024 (HealthDay News) — The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb drinking for people battling alcohol use disorder, helping them to avoid crises that require hospitalization, new research shows. Numerous studies had already hinted that semaglutide might act on appetite centers in the brain toContinue Reading

WEDNESDAY, Nov. 13, 2024 (HealthDay News) — People are at higher risk of schizophrenia if they indulge in psychedelic drugs, a new study warns. Patients who land in the ER following hallucinogen use have a 21-fold higher risk of developing schizophrenia compared to the general population, Canadian researchers report. EvenContinue Reading

MONDAY, Nov. 11, 2024 (HealthDay News) — Asthma is associated with memory problems in children, a new study has found. Further, the early onset of asthma might worsen potential memory deficits in kids, researchers found. This is the first study to make such a connection, researchers said. “This study underscoresContinue Reading